USANA Health Sciences Inc (USNA)
Profitability ratios
Return on sales
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit margin | 80.62% | 80.33% | 80.30% | 80.19% | 80.32% | 80.47% | 80.82% | 81.36% | 81.38% | 81.36% | 81.33% | 80.96% | 81.35% | 81.98% | 82.14% | 82.20% | 82.33% | 82.58% | 82.78% | 83.15% |
| Operating profit margin | 10.08% | 9.83% | 10.15% | 10.38% | 10.74% | 11.19% | 12.44% | 13.77% | 14.30% | 15.48% | 15.56% | 15.40% | 15.51% | 15.38% | 15.00% | 14.24% | 13.78% | 13.80% | 14.25% | 15.40% |
| Pretax margin | 11.10% | 10.61% | 10.67% | 10.63% | 10.84% | 11.28% | 12.43% | 13.82% | 14.34% | 15.66% | 15.69% | 15.52% | 15.64% | 15.45% | 15.21% | 14.54% | 14.19% | 14.16% | 14.65% | 15.71% |
| Net profit margin | 6.91% | 6.43% | 6.67% | 6.68% | 6.92% | 7.38% | 8.25% | 9.38% | 9.79% | 10.99% | 11.04% | 10.91% | 10.96% | 10.57% | 10.36% | 9.76% | 9.48% | 9.38% | 9.68% | 10.38% |
USANA Health Sciences Inc has shown consistent and relatively high profitability ratios over the past few quarters. The gross profit margin has remained strong, ranging from 80.19% to 80.62%, indicating efficient control over production costs and pricing strategies.
The operating profit margin has slightly fluctuated but generally stayed above 9%, indicating effective management of operating expenses. The trend towards improvement from 10.08% to 15.48% over the quarters highlights the company's ability to generate profits from core business operations.
The pretax margin has also been stable, with a range of 10.61% to 15.71%, reflecting the company's ability to manage non-operating expenses and generate earnings before taxes.
Furthermore, the net profit margin has shown consistency and even improvement over the quarters, ranging from 6.43% to 11.04%. This indicates efficient overall management of expenses, taxes, and interest payments to generate net income.
Overall, USANA Health Sciences Inc has demonstrated solid profitability performance, with strong margins across gross, operating, pretax, and net profit levels, showcasing effective cost management and revenue generation strategies.
Return on investment
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | 14.71% | 15.20% | 16.00% | 16.74% | 18.04% | 20.96% | 24.14% | 27.76% | 29.46% | 33.03% | 33.11% | 31.08% | 27.54% | 29.18% | 30.97% | 31.70% | 28.28% | 32.43% | 30.10% | 32.67% |
| Return on assets (ROA) | 10.08% | 9.95% | 10.52% | 10.78% | 11.63% | 13.82% | 16.00% | 18.91% | 20.17% | 23.46% | 23.50% | 22.02% | 19.45% | 20.05% | 21.38% | 21.72% | 19.45% | 22.05% | 20.46% | 22.02% |
| Return on total capital | 20.66% | 21.00% | 21.64% | 22.85% | 25.04% | 28.62% | 33.38% | 40.95% | 43.20% | 48.23% | 47.24% | 45.59% | 40.41% | 43.91% | 46.15% | 48.31% | 42.81% | 49.07% | 42.91% | 46.99% |
| Return on equity (ROE) | 12.83% | 12.72% | 13.52% | 14.33% | 15.96% | 18.70% | 22.12% | 27.79% | 29.49% | 34.03% | 33.20% | 31.96% | 28.23% | 29.76% | 31.37% | 32.40% | 28.58% | 32.49% | 28.35% | 31.04% |
USANA Health Sciences Inc's profitability ratios show a consistent performance over the periods analyzed.
- Operating return on assets (Operating ROA) has been fairly stable, ranging from 14.71% to 33.11%, indicating the company's ability to generate profits from its operating assets. There was a peak at 33.11% in the third quarter of 2021, showing a high efficiency in asset utilization.
- Return on assets (ROA) has also shown a steady trend, fluctuating between 9.95% and 23.50%. The company has managed to generate positive returns on its total assets, with higher peaks in the second quarter of 2021 and 2022.
- Return on total capital indicates a strong performance, with a range of 20.66% to 49.07%. This ratio shows how well the company is utilizing its total capital to generate profits. The highest return was recorded in the first quarter of 2023.
- Return on equity (ROE) has been consistent, ranging from 12.72% to 34.03%. This ratio measures the profitability of the company from the perspective of its shareholders. The peak ROE was observed in the second quarter of 2021, indicating high returns for equity investors.
Overall, USANA Health Sciences Inc has maintained healthy profitability ratios over the periods analyzed, demonstrating efficient asset utilization, strong returns on capital, and consistent returns for equity investors.